Novo Growth is a private equity general partner firm headquartered in Hellerup, Denmark.
iRhythm Technologies, a digital health care solutions provider focused on cardiac care, priced its 6.29m shares at $17 per share in its IPO.
F2G, a UK-based antifungal drug discovery and development company, raised $60m in funding from Novo A/S, Aisling Capital and others.
Rgenix, a NY-based cancer therapeutics company, has raised $33m in Series B financing led by Novo A/S and Sofinnova Partners.
Read more news concerning Novo Growth
A sampling of Novo Growth portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?